May 19 (Reuters) - EU Medicines Agency:
* EU Medicines Agency recommends approval of Valeant Pharmaceuticals (NYSE:VRX) Inc psoriasis drug Brodalumab
* EU Medicines Agency recommends approval of Richter Gedeon and Recordati Industria Chimica E Farmaceutica SPA Cariprazine drug for bipolar mania and schizophrenia
* EU Medicines Agency recommends against approval of AB Science mastocytosis drug Masitinib Source text ID: Further company coverage: GDRB.BU